Endovia Health Sciences, Inc. (AMEX: EDVA) Stock Competitors & Peer Comparison
See EDVA's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for EDVA and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EDVA | $0.14 | -7.53% | 871.5K | -0.01 | -$21.23 | N/A |
| HCA | $454.88 | -0.86% | 98.5B | 15.70 | $28.96 | +0.67% |
| THC | $266.39 | -0.32% | 21.4B | 15.45 | $17.24 | N/A |
| EHC | $121.71 | -4.82% | 12B | 20.84 | $5.84 | +0.64% |
| DVA | $187.00 | -0.17% | 11.9B | 14.62 | $12.80 | N/A |
| FMS | $21.94 | -1.04% | 11.7B | 8.24 | $2.66 | +3.94% |
| UHS | $182.29 | -1.52% | 10.7B | 8.09 | $22.54 | +0.44% |
| ENSG | $173.05 | -2.03% | 10.1B | 25.07 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| PACS | $45.85 | -2.26% | 7.3B | 24.25 | $1.89 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
EDVA vs HCA Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, HCA has a market cap of 98.5B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while HCA trades at $454.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas HCA's P/E ratio is 15.70. In terms of profitability, EDVA's ROE is N/A, compared to HCA's ROE of -1.13%. Regarding short-term risk, EDVA is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
EDVA vs THC Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, THC has a market cap of 21.4B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while THC trades at $266.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas THC's P/E ratio is 15.45. In terms of profitability, EDVA's ROE is N/A, compared to THC's ROE of +0.51%. Regarding short-term risk, EDVA is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
EDVA vs EHC Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, EHC has a market cap of 12B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while EHC trades at $121.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas EHC's P/E ratio is 20.84. In terms of profitability, EDVA's ROE is N/A, compared to EHC's ROE of +0.25%. Regarding short-term risk, EDVA is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check EHC's competition here
DaVita Inc. (NYSE: DVA)
EDVA vs DVA Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, DVA has a market cap of 11.9B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while DVA trades at $187.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas DVA's P/E ratio is 14.62. In terms of profitability, EDVA's ROE is N/A, compared to DVA's ROE of -1.24%. Regarding short-term risk, EDVA is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check DVA's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
EDVA vs FMS Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, FMS has a market cap of 11.7B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while FMS trades at $21.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas FMS's P/E ratio is 8.24. In terms of profitability, EDVA's ROE is N/A, compared to FMS's ROE of +0.07%. Regarding short-term risk, EDVA is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check FMS's competition here
Universal Health Services, Inc. (NYSE: UHS)
EDVA vs UHS Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, UHS has a market cap of 10.7B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while UHS trades at $182.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas UHS's P/E ratio is 8.09. In terms of profitability, EDVA's ROE is N/A, compared to UHS's ROE of +0.21%. Regarding short-term risk, EDVA is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
EDVA vs ENSG Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, ENSG has a market cap of 10.1B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while ENSG trades at $173.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas ENSG's P/E ratio is 25.07. In terms of profitability, EDVA's ROE is N/A, compared to ENSG's ROE of +0.17%. Regarding short-term risk, EDVA is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
EDVA vs OSH Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas OSH's P/E ratio is -17.65. In terms of profitability, EDVA's ROE is N/A, compared to OSH's ROE of +4.64%. Regarding short-term risk, EDVA is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
EDVA vs PACS Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, PACS has a market cap of 7.3B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while PACS trades at $45.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas PACS's P/E ratio is 24.25. In terms of profitability, EDVA's ROE is N/A, compared to PACS's ROE of +0.27%. Regarding short-term risk, EDVA is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
EDVA vs CHE Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, CHE has a market cap of 6.7B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while CHE trades at $508.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas CHE's P/E ratio is 23.54. In terms of profitability, EDVA's ROE is N/A, compared to CHE's ROE of +0.29%. Regarding short-term risk, EDVA is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
EDVA vs HIMS Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, HIMS has a market cap of 6.3B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while HIMS trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas HIMS's P/E ratio is -43.96. In terms of profitability, EDVA's ROE is N/A, compared to HIMS's ROE of -0.30%. Regarding short-term risk, EDVA is more volatile compared to HIMS. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check HIMS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
EDVA vs LHCG Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas LHCG's P/E ratio is 82.83. In terms of profitability, EDVA's ROE is N/A, compared to LHCG's ROE of +0.04%. Regarding short-term risk, EDVA is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check LHCG's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
EDVA vs CON Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, CON has a market cap of 4.9B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while CON trades at $38.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas CON's P/E ratio is 24.01. In terms of profitability, EDVA's ROE is N/A, compared to CON's ROE of +0.47%. Regarding short-term risk, EDVA is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
EDVA vs OPCH Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, OPCH has a market cap of 4.7B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while OPCH trades at $31.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas OPCH's P/E ratio is 18.14. In terms of profitability, EDVA's ROE is N/A, compared to OPCH's ROE of +0.16%. Regarding short-term risk, EDVA is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check OPCH's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
EDVA vs LFST Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, LFST has a market cap of 4.5B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while LFST trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas LFST's P/E ratio is 88.65. In terms of profitability, EDVA's ROE is N/A, compared to LFST's ROE of +0.03%. Regarding short-term risk, EDVA is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check LFST's competition here
National HealthCare Corporation (AMEX: NHC)
EDVA vs NHC Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, NHC has a market cap of 3.8B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while NHC trades at $239.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas NHC's P/E ratio is 30.55. In terms of profitability, EDVA's ROE is N/A, compared to NHC's ROE of +0.13%. Regarding short-term risk, EDVA is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
EDVA vs AMED Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AMED's P/E ratio is 39.30. In terms of profitability, EDVA's ROE is N/A, compared to AMED's ROE of +0.04%. Regarding short-term risk, EDVA is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
EDVA vs ACHC Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, ACHC has a market cap of 2.8B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while ACHC trades at $30.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas ACHC's P/E ratio is 15.17. In terms of profitability, EDVA's ROE is N/A, compared to ACHC's ROE of -0.50%. Regarding short-term risk, EDVA is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check ACHC's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
EDVA vs AVAH Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AVAH has a market cap of 2.7B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AVAH trades at $12.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AVAH's P/E ratio is 18.29. In terms of profitability, EDVA's ROE is N/A, compared to AVAH's ROE of +1.50%. Regarding short-term risk, EDVA is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
EDVA vs GRDN Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, GRDN has a market cap of 2.5B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while GRDN trades at $40.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas GRDN's P/E ratio is 35.19. In terms of profitability, EDVA's ROE is N/A, compared to GRDN's ROE of +0.31%. Regarding short-term risk, EDVA is more volatile compared to GRDN. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check GRDN's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
EDVA vs BKD Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, BKD has a market cap of 2.4B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while BKD trades at $9.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas BKD's P/E ratio is -17.00. In terms of profitability, EDVA's ROE is N/A, compared to BKD's ROE of +4.06%. Regarding short-term risk, EDVA is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check BKD's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
EDVA vs MD Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while MD trades at $27.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas MD's P/E ratio is 12.19. In terms of profitability, EDVA's ROE is N/A, compared to MD's ROE of +0.20%. Regarding short-term risk, EDVA is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
EDVA vs ADUS Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while ADUS trades at $115.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas ADUS's P/E ratio is 17.24. In terms of profitability, EDVA's ROE is N/A, compared to ADUS's ROE of +0.10%. Regarding short-term risk, EDVA is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
EDVA vs SEM Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, SEM has a market cap of 2B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas SEM's P/E ratio is 15.43. In terms of profitability, EDVA's ROE is N/A, compared to SEM's ROE of +0.08%. Regarding short-term risk, EDVA is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check SEM's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
EDVA vs SGRY Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while SGRY trades at $14.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas SGRY's P/E ratio is 37.72. In terms of profitability, EDVA's ROE is N/A, compared to SGRY's ROE of -0.05%. Regarding short-term risk, EDVA is more volatile compared to SGRY. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check SGRY's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
EDVA vs ASTH Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while ASTH trades at $36.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas ASTH's P/E ratio is 44.46. In terms of profitability, EDVA's ROE is N/A, compared to ASTH's ROE of +0.05%. Regarding short-term risk, EDVA is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check ASTH's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
EDVA vs AMEH Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AMEH's P/E ratio is 39.25. In terms of profitability, EDVA's ROE is N/A, compared to AMEH's ROE of +0.05%. Regarding short-term risk, EDVA is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check AMEH's competition here
Ardent Health Inc. (NYSE: ARDT)
EDVA vs ARDT Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while ARDT trades at $11.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas ARDT's P/E ratio is 9.43. In terms of profitability, EDVA's ROE is N/A, compared to ARDT's ROE of +0.05%. Regarding short-term risk, EDVA is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check ARDT's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
EDVA vs SNDA Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, SNDA has a market cap of 1.6B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while SNDA trades at $34.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas SNDA's P/E ratio is -5.50. In terms of profitability, EDVA's ROE is N/A, compared to SNDA's ROE of -0.26%. Regarding short-term risk, EDVA is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check SNDA's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
EDVA vs AMN Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AMN has a market cap of 1.6B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AMN trades at $40.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AMN's P/E ratio is 13.44. In terms of profitability, EDVA's ROE is N/A, compared to AMN's ROE of +0.15%. Regarding short-term risk, EDVA is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check AMN's competition here
Agilon Health, Inc. (NYSE: AGL)
EDVA vs AGL Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AGL has a market cap of 1.5B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AGL trades at $88.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AGL's P/E ratio is -5.76. In terms of profitability, EDVA's ROE is N/A, compared to AGL's ROE of -1.19%. Regarding short-term risk, EDVA is more volatile compared to AGL. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check AGL's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
EDVA vs HCSG Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, HCSG has a market cap of 1.4B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while HCSG trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas HCSG's P/E ratio is 16.89. In terms of profitability, EDVA's ROE is N/A, compared to HCSG's ROE of +0.24%. Regarding short-term risk, EDVA is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check HCSG's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
EDVA vs PNTG Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while PNTG trades at $40.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas PNTG's P/E ratio is 30.80. In terms of profitability, EDVA's ROE is N/A, compared to PNTG's ROE of +0.10%. Regarding short-term risk, EDVA is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check PNTG's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
EDVA vs NUTX Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while NUTX trades at $191.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas NUTX's P/E ratio is 7.58. In terms of profitability, EDVA's ROE is N/A, compared to NUTX's ROE of +0.52%. Regarding short-term risk, EDVA is more volatile compared to NUTX. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check NUTX's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
EDVA vs USPH Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, USPH has a market cap of 1.3B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while USPH trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas USPH's P/E ratio is 33.08. In terms of profitability, EDVA's ROE is N/A, compared to USPH's ROE of -0.01%. Regarding short-term risk, EDVA is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check USPH's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
EDVA vs BKDT Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas BKDT's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to BKDT's ROE of +4.06%. Regarding short-term risk, EDVA is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check BKDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
EDVA vs INNV Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while INNV trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas INNV's P/E ratio is -444.00. In terms of profitability, EDVA's ROE is N/A, compared to INNV's ROE of -0.01%. Regarding short-term risk, EDVA is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check INNV's competition here
Talkspace, Inc. (NASDAQ: TALK)
EDVA vs TALK Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, TALK has a market cap of 870.6M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas TALK's P/E ratio is 774.34. In terms of profitability, EDVA's ROE is N/A, compared to TALK's ROE of +0.00%. Regarding short-term risk, EDVA is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check TALK's competition here
Enhabit, Inc. (NYSE: EHAB)
EDVA vs EHAB Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas EHAB's P/E ratio is -197.14. In terms of profitability, EDVA's ROE is N/A, compared to EHAB's ROE of -0.01%. Regarding short-term risk, EDVA is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
EDVA vs STLN Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, STLN has a market cap of 644.9M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while STLN trades at $6.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas STLN's P/E ratio is -21.13. In terms of profitability, EDVA's ROE is N/A, compared to STLN's ROE of +2.10%. Regarding short-term risk, EDVA is more volatile compared to STLN. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check STLN's competition here
GMR Solutions Inc. (NYSE: GMRS)
EDVA vs GMRS Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, GMRS has a market cap of 540.2M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while GMRS trades at $9.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas GMRS's P/E ratio is -4.93. In terms of profitability, EDVA's ROE is N/A, compared to GMRS's ROE of +0.16%. Regarding short-term risk, EDVA is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
EDVA vs TOI Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas TOI's P/E ratio is -14.25. In terms of profitability, EDVA's ROE is N/A, compared to TOI's ROE of +2.10%. Regarding short-term risk, EDVA is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check TOI's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
EDVA vs MCTA Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas MCTA's P/E ratio is 419.36. In terms of profitability, EDVA's ROE is N/A, compared to MCTA's ROE of -2.33%. Regarding short-term risk, EDVA is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
EDVA vs SRTA Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, SRTA has a market cap of 401.6M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while SRTA trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas SRTA's P/E ratio is -21.40. In terms of profitability, EDVA's ROE is N/A, compared to SRTA's ROE of +0.14%. Regarding short-term risk, EDVA is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check SRTA's competition here
Auna S.A. (NYSE: AUNA)
EDVA vs AUNA Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AUNA has a market cap of 399.7M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AUNA trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AUNA's P/E ratio is 4.86. In terms of profitability, EDVA's ROE is N/A, compared to AUNA's ROE of +0.01%. Regarding short-term risk, EDVA is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check AUNA's competition here
Community Health Systems, Inc. (NYSE: CYH)
EDVA vs CYH Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, CYH has a market cap of 389.9M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while CYH trades at $2.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas CYH's P/E ratio is 3.79. In terms of profitability, EDVA's ROE is N/A, compared to CYH's ROE of +0.21%. Regarding short-term risk, EDVA is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check CYH's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
EDVA vs VMD Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, VMD has a market cap of 365.3M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while VMD trades at $9.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas VMD's P/E ratio is 26.64. In terms of profitability, EDVA's ROE is N/A, compared to VMD's ROE of +0.10%. Regarding short-term risk, EDVA is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
EDVA vs CSU Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas CSU's P/E ratio is 0.67. In terms of profitability, EDVA's ROE is N/A, compared to CSU's ROE of -0.33%. Regarding short-term risk, EDVA is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
EDVA vs JYNT Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, JYNT has a market cap of 103.7M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while JYNT trades at $7.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas JYNT's P/E ratio is 48.87. In terms of profitability, EDVA's ROE is N/A, compared to JYNT's ROE of +0.22%. Regarding short-term risk, EDVA is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
EDVA vs FVE Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas FVE's P/E ratio is -5.64. In terms of profitability, EDVA's ROE is N/A, compared to FVE's ROE of -0.15%. Regarding short-term risk, EDVA is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
EDVA vs KDLYW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas KDLYW's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, EDVA is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check KDLYW's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
EDVA vs AIRS Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AIRS has a market cap of 89.8M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AIRS trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AIRS's P/E ratio is -41.50. In terms of profitability, EDVA's ROE is N/A, compared to AIRS's ROE of -0.13%. Regarding short-term risk, EDVA is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check AIRS's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
EDVA vs PARK Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, PARK has a market cap of 89.7M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while PARK trades at $18.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas PARK's P/E ratio is 25.49. In terms of profitability, EDVA's ROE is N/A, compared to PARK's ROE of -0.18%. Regarding short-term risk, EDVA is more volatile compared to PARK. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
EDVA vs BTMD Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, BTMD has a market cap of 47.2M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while BTMD trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas BTMD's P/E ratio is 9.73. In terms of profitability, EDVA's ROE is N/A, compared to BTMD's ROE of -0.09%. Regarding short-term risk, EDVA is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check BTMD's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
EDVA vs EUDA Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, EUDA has a market cap of 46.9M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while EUDA trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas EUDA's P/E ratio is -13.46. In terms of profitability, EDVA's ROE is N/A, compared to EUDA's ROE of -5.06%. Regarding short-term risk, EDVA is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check EUDA's competition here
AlerisLife Inc. (NASDAQ: ALR)
EDVA vs ALR Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas ALR's P/E ratio is -1.11. In terms of profitability, EDVA's ROE is N/A, compared to ALR's ROE of -0.15%. Regarding short-term risk, EDVA is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check ALR's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
EDVA vs CCEL Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, CCEL has a market cap of 36.8M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while CCEL trades at $4.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas CCEL's P/E ratio is -19.87. In terms of profitability, EDVA's ROE is N/A, compared to CCEL's ROE of +0.16%. Regarding short-term risk, EDVA is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
EDVA vs IMAC Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas IMAC's P/E ratio is -2.27. In terms of profitability, EDVA's ROE is N/A, compared to IMAC's ROE of +0.00%. Regarding short-term risk, EDVA is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check IMAC's competition here
DocGo Inc. (NASDAQ: DCGO)
EDVA vs DCGO Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, DCGO has a market cap of 25.2M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while DCGO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas DCGO's P/E ratio is -0.14. In terms of profitability, EDVA's ROE is N/A, compared to DCGO's ROE of -1.16%. Regarding short-term risk, EDVA is more volatile compared to DCGO. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check DCGO's competition here
Cano Health, Inc. (NYSE: CANO-WT)
EDVA vs CANO-WT Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, EDVA is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check CANO-WT's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
EDVA vs PIIIW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, PIIIW has a market cap of 19.1M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas PIIIW's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, EDVA is less volatile compared to PIIIW. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check PIIIW's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
EDVA vs AIH Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AIH's P/E ratio is -2.78. In terms of profitability, EDVA's ROE is N/A, compared to AIH's ROE of +1.16%. Regarding short-term risk, EDVA is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
EDVA vs PIII Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, PIII has a market cap of 12.9M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while PIII trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas PIII's P/E ratio is -0.12. In terms of profitability, EDVA's ROE is N/A, compared to PIII's ROE of +1.61%. Regarding short-term risk, EDVA is more volatile compared to PIII. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO)
EDVA vs CANO Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas CANO's P/E ratio is -0.01. In terms of profitability, EDVA's ROE is N/A, compared to CANO's ROE of -1.49%. Regarding short-term risk, EDVA is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
EDVA vs FPCG Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas FPCG's P/E ratio is 0.09. In terms of profitability, EDVA's ROE is N/A, compared to FPCG's ROE of +0.00%. Regarding short-term risk, EDVA is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
EDVA vs FTRP Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas FTRP's P/E ratio is -1.22. In terms of profitability, EDVA's ROE is N/A, compared to FTRP's ROE of -0.62%. Regarding short-term risk, EDVA is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
EDVA vs AMS Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AMS has a market cap of 8.3M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AMS trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AMS's P/E ratio is -4.93. In terms of profitability, EDVA's ROE is N/A, compared to AMS's ROE of -0.07%. Regarding short-term risk, EDVA is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
EDVA vs BMGL Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, BMGL has a market cap of 6.4M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while BMGL trades at $4.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas BMGL's P/E ratio is -0.81. In terms of profitability, EDVA's ROE is N/A, compared to BMGL's ROE of -1.64%. Regarding short-term risk, EDVA is more volatile compared to BMGL. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check BMGL's competition here
ModivCare Inc. (NASDAQ: MODV)
EDVA vs MODV Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas MODV's P/E ratio is -0.06. In terms of profitability, EDVA's ROE is N/A, compared to MODV's ROE of +0.88%. Regarding short-term risk, EDVA is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
EDVA vs GBNH Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas GBNH's P/E ratio is -0.06. In terms of profitability, EDVA's ROE is N/A, compared to GBNH's ROE of +15.74%. Regarding short-term risk, EDVA is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
EDVA vs RHE Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas RHE's P/E ratio is -1.79. In terms of profitability, EDVA's ROE is N/A, compared to RHE's ROE of -1.31%. Regarding short-term risk, EDVA is more volatile compared to RHE. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
EDVA vs RHE-PA Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, EDVA's ROE is N/A, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, EDVA is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check RHE-PA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
EDVA vs TOIIW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, EDVA's ROE is N/A, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, EDVA is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check TOIIW's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
EDVA vs AIDX Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AIDX has a market cap of 3.3M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AIDX trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AIDX's P/E ratio is -0.36. In terms of profitability, EDVA's ROE is N/A, compared to AIDX's ROE of -3.87%. Regarding short-term risk, EDVA is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check AIDX's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
EDVA vs STLNW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, STLNW has a market cap of 2.8M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while STLNW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas STLNW's P/E ratio is -0.09. In terms of profitability, EDVA's ROE is N/A, compared to STLNW's ROE of +2.10%. Regarding short-term risk, EDVA is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check STLNW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
EDVA vs IMACW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas IMACW's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to IMACW's ROE of +0.46%. Regarding short-term risk, EDVA is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check IMACW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
EDVA vs EUDAW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, EUDAW has a market cap of 971.7K. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas EUDAW's P/E ratio is -0.02. In terms of profitability, EDVA's ROE is N/A, compared to EUDAW's ROE of -5.06%. Regarding short-term risk, EDVA is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
EDVA vs CCM Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, CCM has a market cap of 516.7K. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while CCM trades at $3.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas CCM's P/E ratio is -1.20. In terms of profitability, EDVA's ROE is N/A, compared to CCM's ROE of +0.05%. Regarding short-term risk, EDVA is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
EDVA vs NIVFW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, NIVFW has a market cap of 35K. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas NIVFW's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to NIVFW's ROE of -292.08%. Regarding short-term risk, EDVA is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
EDVA vs TALKW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas TALKW's P/E ratio is 0.00. In terms of profitability, EDVA's ROE is N/A, compared to TALKW's ROE of +0.00%. Regarding short-term risk, EDVA is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
EDVA vs MNDR Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, MNDR has a market cap of 22.5K. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while MNDR trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas MNDR's P/E ratio is -0.06. In terms of profitability, EDVA's ROE is N/A, compared to MNDR's ROE of -0.46%. Regarding short-term risk, EDVA is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check MNDR's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
EDVA vs TNONW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, TNONW has a market cap of 5.1K. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while TNONW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas TNONW's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to TNONW's ROE of N/A. Regarding short-term risk, EDVA is less volatile compared to TNONW. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check TNONW's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
EDVA vs NIVF Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, NIVF has a market cap of 4.4K. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while NIVF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas NIVF's P/E ratio is 0.14. In terms of profitability, EDVA's ROE is N/A, compared to NIVF's ROE of -292.08%. Regarding short-term risk, EDVA is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check NIVF's competition here
New Frontier Health Corporation (NYSE: NFH)
EDVA vs NFH Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, NFH has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas NFH's P/E ratio is -19.75. In terms of profitability, EDVA's ROE is N/A, compared to NFH's ROE of -0.06%. Regarding short-term risk, EDVA is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check NFH's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
EDVA vs TVTY Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, TVTY has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas TVTY's P/E ratio is 19.06. In terms of profitability, EDVA's ROE is N/A, compared to TVTY's ROE of +1.75%. Regarding short-term risk, EDVA is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check TVTY's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
EDVA vs ATIP-WT Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, EDVA is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for EDVA.Check ATIP-WT's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
EDVA vs SLHGP Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, EDVA's ROE is N/A, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, EDVA is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check SLHGP's competition here
Kindred Healthcare, Inc. (NYSE: KND)
EDVA vs KND Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, KND has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas KND's P/E ratio is -1.14. In terms of profitability, EDVA's ROE is N/A, compared to KND's ROE of -0.53%. Regarding short-term risk, EDVA is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check KND's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
EDVA vs SLHG Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, SLHG has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas SLHG's P/E ratio is -1.48. In terms of profitability, EDVA's ROE is N/A, compared to SLHG's ROE of N/A. Regarding short-term risk, EDVA is more volatile compared to SLHG. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check SLHG's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
EDVA vs TLMDW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas TLMDW's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, EDVA is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check TLMDW's competition here
DocGo Inc. (NASDAQ: DCGOW)
EDVA vs DCGOW Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas DCGOW's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, EDVA is more volatile compared to DCGOW. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check DCGOW's competition here
Hanger, Inc. (NYSE: HNGR)
EDVA vs HNGR Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, HNGR has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas HNGR's P/E ratio is 19.71. In terms of profitability, EDVA's ROE is N/A, compared to HNGR's ROE of +0.52%. Regarding short-term risk, EDVA is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check HNGR's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
EDVA vs DVCR Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, DVCR has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas DVCR's P/E ratio is 28.34. In terms of profitability, EDVA's ROE is N/A, compared to DVCR's ROE of -0.15%. Regarding short-term risk, EDVA is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check DVCR's competition here
Almost Family Inc. (NASDAQ: AFAM)
EDVA vs AFAM Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, AFAM has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas AFAM's P/E ratio is N/A. In terms of profitability, EDVA's ROE is N/A, compared to AFAM's ROE of +0.06%. Regarding short-term risk, EDVA is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
EDVA vs TLMD Comparison October 2026
Endovia Health Sciences, Inc. (AMEX: EDVA) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EDVA stands at 871.5K. In comparison, TLMD has a market cap of 0. Regarding current trading prices, EDVA is priced at $0.14 on the AMEX, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EDVA currently has a P/E ratio of -0.01, whereas TLMD's P/E ratio is -1.60. In terms of profitability, EDVA's ROE is N/A, compared to TLMD's ROE of -0.46%. Regarding short-term risk, EDVA is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for EDVA.Check TLMD's competition here